127 related articles for article (PubMed ID: 17306873)
1. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
Leuk Res; 2007 Sep; 31(9):1293-301. PubMed ID: 17306873
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
Sancho P; Fernández C; Yuste VJ; Amrán D; Ramos AM; de Blas E; Susin SA; Aller P
Apoptosis; 2006 May; 11(5):673-86. PubMed ID: 16532269
[TBL] [Abstract][Full Text] [Related]
3. Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid.
Furuke K; Sasada T; Ueda-Taniguchi Y; Yamauchi A; Inamoto T; Yamaoka Y; Masutani H; Yodoi J
Cancer Res; 1997 Nov; 57(21):4916-23. PubMed ID: 9354458
[TBL] [Abstract][Full Text] [Related]
4. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells.
D'Alessio M; Cerella C; Amici C; Pesce C; Coppola S; Fanelli C; De Nicola M; Cristofanon S; Clavarino G; Bergamaschi A; Magrini A; Gualandi G; Ghibelli L
FASEB J; 2004 Oct; 18(13):1609-11. PubMed ID: 15289449
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
6. Oxidative upregulation of Bcl-2 in healthy lymphocytes.
Cristofanon S; Nuccitelli S; D'Alessio M; Radogna F; De Nicola M; Bergamaschi A; Cerella C; Magrini A; Diederich M; Ghibelli L
Ann N Y Acad Sci; 2006 Dec; 1091():1-9. PubMed ID: 17341597
[TBL] [Abstract][Full Text] [Related]
7. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
[TBL] [Abstract][Full Text] [Related]
8. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
11. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.
Reber U; Wüllner U; Trepel M; Baumgart J; Seyfried J; Klockgether T; Dichgans J; Weller M
Biochem Pharmacol; 1998 Feb; 55(3):349-59. PubMed ID: 9484802
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Duechler M; Stańczyk M; Czyz M; Stepnik M
Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
[TBL] [Abstract][Full Text] [Related]
14. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
15. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.
Anderson CP; Seeger RC; Satake N; Monforte-Munoz HL; Keshelava N; Bailey HH; Reynolds CP
J Pediatr Hematol Oncol; 2001 Nov; 23(8):500-5. PubMed ID: 11878777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
Yoshida A; Takemura H; Inoue H; Miyashita T; Ueda T
Cancer Res; 2006 Jun; 66(11):5772-80. PubMed ID: 16740716
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
[TBL] [Abstract][Full Text] [Related]
18. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
19. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress.
Langie SA; Knaapen AM; Houben JM; van Kempen FC; de Hoon JP; Gottschalk RW; Godschalk RW; van Schooten FJ
Toxicol Lett; 2007 Feb; 168(3):302-9. PubMed ID: 17207589
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes.
Muyderman H; Wadey AL; Nilsson M; Sims NR
J Neurochem; 2007 Aug; 102(4):1369-82. PubMed ID: 17484727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
